Frazier Life Sciences
Signal active
Investment Firm
Overview
Frazier Life Sciences invests globally in private and publicly-traded companies that discover and commercialize biopharmaceuticals.
Highlights
Founded
Invalid date
Industry
Financial Services
Employees
11-50
Investment
3
Lead Investment
1
Exits
undefined
Stages
Early Stage Venture, Late Stage Venture
Investor Type
Venture Capital
Location
United States, North America
Contact Information
Social
Profile Resume
Frazier Life Sciences, established in Unknown year and headquartered in United States, North America., specializes in Early Stage Venture, Late Stage Venture investments across Biotechnology, Medical, Therapeutics, Venture Capital, FinTech, Biopharma, Information Technology, Energy, Media and Entertainment, Financial Services. Their recent investments include Halda Therapeutics, Canaan Partners, Connecticut Innovations, Elm Street Ventures, RA Capital Management. The highest investment round they participated in was $59.3B. Among their most notable exits are Halda Therapeutics and Canaan Partners. Explore their portfolio in detail, see who is connected to them, and find their contact information on our platform.
Investment portfolio
Frazier Life Sciences has made 3 investments. Their most recent investment was on Aug 12, 2024, when Halda Therapeutics raised $126.0M.
Frazier Life Sciences has made 1 diversity investments. Their most recent diversity investment was on May 09, 2024, when Bluejay Therapeutics raised $182.0M.
investments
3
Diversity investments
1
Lead investments
1
Number of exits
undefined
Investments
3
| Annouced Date | Organization Name | Industry | Money Raised |
|---|---|---|---|
| Mar 14, 2024 | - | - | 139.3M |
| May 09, 2024 | Bluejay Therapeutics | Biotechnology | 182.0M |
| Aug 12, 2024 | Halda Therapeutics | Biotechnology | 126.0M |
Exits
0
Funding Timeline
Funding rounds
3
Investors
0
Funds
0
Funding Rounds
3
Frazier Life Sciences has raised 3 rounds. Their latest funding was raised on Aug 12, 2024 from a Series B - Halda Therapeutics round.
| Annouced Date | Transaction Name | Number of Investors | Money Raised | Lead Investor |
|---|---|---|---|---|
| Mar 14, 2024 | Series B - Tubulis | - | 139.3M | - |
| May 09, 2024 | Series C - Bluejay Therapeutics | - | 182.0M | - |
| Aug 12, 2024 | Series B - Halda Therapeutics | - | 126.0M | - |
Investors
0
There is no funding round available on this profile
Fund raised
2
Susa Ventures has raised a total of $590M across 6 funds, their latest being Susa Ventures Opportunities II. This fund was announced on Aug 30, 2021 and raised a total of $250M.
| Annouced Date | Fund Name | Money Raised |
|---|---|---|
| May 10, 2013 | OTPPLESS | 1.0M |
| May 11, 2013 | OTPPLESS | 1.0M |
Invest in industries
Recent Activity
There is no recent news or activity for this profile.